Aarti Drugs

Here's why Aarti Drugs shares fell 4% on October 25, more details here

The fall in Aarti Drugs share price came after the company reported a weak set of September quarter (Q2FY25) earnings.

Aarti Drugs shares rise 3% as manufacturing facility gets nod from UK MHRA

Smallcap pharmaceutical company Aarti Drugs's shares climbed up to 2.95 per cent at Rs 528.85 per share on the BSE

Aarti Drugs surges 13% as board mulls share buyback on August 26

Going ahead in FY25, the management anticipates an improvement in margins, mostly driven by an anticipated growth in export sales and backward integration.

Aarti Drugs, Balrampur: 5 stocks that can surge up to 66% in Samvat 2080

Bayer Cropscience, Granules India and HLE Glasscoat are the other three stocks that can generate healthy returns till next Diwali, based on the existing chart patterns.

Aarti Drugs surges 14% on firm Q1 result, approves buyback via tender route

The board has approved the buyback of 665,000 equity shares at Rs 900 per share via the tender offer route

Aarti Drugs advances 15% as board approves buyback at Rs 1,000 per share

The board of directors has fixed April 1 as record date for ascertaining the shareholder who will participate in the proposed buyback.

Aarti Drugs gains 6% as board to consider buyback on March 19

In the past six months, the stock of Aarti Drugs has underperformed the market by falling 7 per cent as against a 29 per cent rally in the Sensex

Stocks to watch: Aarti Drugs, Adani Ports, PVR, IndiGrid, Just Dial

Multiplex major PVR plans to invest Rs 150 crore to open up to 40 screens across the country in the next fiscal

After 29% rally in H1FY21, the best in a decade, analysts cautious on mkts

Economists caution that the demand for goods and services could taper off in the months ahead

Aarti Drugs leaps 15%, hits new high as board approves 3:1 bonus shares

The company will intimate the "Record Date" for determining eligible shareholders entitled to receive bonus shares in due course

Aarti Drugs shares surge 13% on bonus issue plan announcement

The company had reported 281 per cent jump in net profit in June 2020 quarter results.

Aarti Drugs to Tata Comm: Earnings rise for 15 firms in Covid-19 economy

These companies reported an increase in revenue and/or profit before tax for the March quarter

Aarti Drugs hits fresh all-time high; stock zooms 165% in 3 months

According to analysts at Centrum Broking, the launch of new products would improve the company's margins in the coming quarters

Market Ahead, May 15: All You Need To Know Before The Opening Bell

Today, a total of 12 companies including Cipla, Aaarti Drugs, and M&M Finance are scheduled to announce their results

Aarti Drugs nears 5-year high; stock rallies 26% in 5 days in a weak market

Analysts believe the firm's API business will continue its growth momentum driven by capacity expansion and gain in market share in existing products

Aarti Drugs falls 6% as Tarapur unit impacted by explosion

The stock dipped 6% to Rs 528 on the BSE in otherwise firm market.

Aarti Drugs surges 7% on board nod for share buyback

The stock hit a fresh 52-week high of Rs 785, up 7% on BSE in intra-day trade, after the company's board share buyback at a price of Rs 875 per share through tender offer.

Aarti Drugs hits 52-week high on share buyback plan

The stock surged 7% to Rs 689, also its 52-week high on NSE in early morning trade after the company said that its board will meet on January 8, to consider share buyback proposal